Embecta Corp
Închisă
SectorSănătate
3.1 0.98
Rezumat
Modificarea prețului
24h
Minim
3.03
Maxim
3.12
Venit | -48M -4.1M |
|---|---|
Vânzări | -39M 222M |
P/E Medie Sector | 1.643 49.712 |
EPS | 0.27 |
Randament dividend | 19.17 |
Marjă de profit | -1.849 |
Angajați | 1,850 |
EBITDA | -51M 45M |
Recomandări | Vânzare |
|---|---|
Prognoză pe 12 luni | +28.62% upside |
Randament dividend Medie Sector | 19.17% 2.36% |
|---|---|
Următoarele câștiguri | 7 aug. 2026 |
Data viitoare de dividende | 14 sept. 2026 |
Următoarea dată ex-dividende | 28 aug. 2026 |
Capitalizare de piață | -364M 184M |
|---|---|
Deschiderea anterioară | 2.12 |
Închiderea anterioară | 3.1 |
Sentimentul știrilor
By Acuity
63%
37%
275 / 342 Clasament în Healthcare
Embecta Corp Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Despre Embecta Corp
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
